Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies
Process development and scale-up of viral vaccines.
1 June 2021
September 21st (PM), 22nd (Full day) and 23rd (AM)
Vaccine Formulation Insitute (VFI) in collaboration with Merck/M Lab, Molsheim, France
Participant Nr.: 10
Review of the different vaccines modalities (Core and New)
Using a combination of theory and hands-on instruction, participants will learn the following:
Key best practices and methods for vaccine process development from upstream to downstream focusing on a viral vaccine platform.
Best practices of cell culturing in single use bioreactors for both adherent and suspension cells;
Optimization of filtration and purification technologies;
How to integrate vaccine processes in a single use environment;
Understand challenges and integrate key considerations for optimal viral vaccine process development and transition to manufacturing Learn how to implement a single use technology based process for viral vaccines.
Who should apply
This course is designed for R&D scientists and engineers who are or will be responsible for developing and implementing production scale viral vaccine processes.
Prior experience with laboratory scale vaccine and/or biologics process development.
Due to COVID19 this course will be held virtually.
* Due to COVID19 related delays call and training modules' schedule may be subject to change.